All News

Fear, one's faith in the government, and likelihood of exposure are leading factors.

Oncologists recognize the potential of artificial intelligence (AI) in improving the quality of care and patient outcomes according to new research.

Indicated as part of a three-drug oral combination.

The 2018 oncology drug market had a record number of new treatments and continued a trend of growth.

NHE3 inhibitor administered as 50 mg oral tablets.

New medications and treatment guidelines

Patients are still allowed to take medicines as prescribed.

Fentanyl, oxymorphone, and hydrocodone face greatest cuts.

"Community pharmacies have reasons to be optimistic..." writes Jhaveri. 

Current phase 3 studies investigative novel, preventative approaches.

Investigational oral MET kinase inhibitor from Merck.

The age indication for some influenza vaccines has been expanded.

New changes are making it more difficult for generics and biosimilars to compete on formularies.

Technicians, clerks, even front-end cashiers are taking on new responsibilities.

Oral supplements for metabolic disorder. 

Oral kinase inhibitor for SSc-ILD.

First generic specialty injections approved for Novadoz Pharmaceuticals. 

We need to stand up for anywhere our profession has a profound impact on healthcare, writes Kreckel. 

Imaging techniques, stem cell therapy, and more!

Prescriptions for COPD contribute to antimicrobial resistance.

Texas pharmacies worked with “runners” to divert prescription opioids to the streets.

New concept offers dental, lab tests, immunizations, and other services.

Number of reported cases hightest since 1992.

Technology will help connect and engage with younger customers.

Though decreasing, initiatives and awareness will generate more revenue.

Rare instances of worsening liver function reported to FDA.

New results contradict HHS and FDA plans.